News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Neervannan Seshadri
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2023 |
4
| Neervannan Seshadri (COO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 372 shares
@ $12.89, valued at
$4.8k
Sold 379 shares
@ $12.64, valued at
$4.8k
Sold 390 shares
@ $12.15, valued at
$4.7k
|
|
| 03/21/2023 |
4
| Neervannan Seshadri (COO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 360 shares
@ $13.28, valued at
$4.8k
Sold 380 shares
@ $12.61, valued at
$4.8k
|
|
| 03/17/2023 |
4
| Neervannan Seshadri (COO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 357 shares
@ $13.43, valued at
$4.8k
Exercised 5,097 restricted stock units
@ $0 |
|
| 03/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/10/2023 |
4
| Neervannan Seshadri (COO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 48,116 options to buy
@ $15, valued at
$721.7k
Granted 32,592 restricted stock units
@ $0 |
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
3
| Neervannan Seshadri (COO) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
|
|